Koninklijke Philips NV (0LNG)
London Exchange · UK · prices in EUR · close of 21 Oct 2026
Key indicators
| Last close | EUR 23.38 |
|---|---|
| 52-week range | 19.65 – 26.67 |
| Return, 1 month / 3 months | +7.0% / +2.0% |
| Return, 1 year / 3 years | −1.1% / +52.4% |
| Trend | Uptrend |
| RSI (14) | 69 |
| Volatility (1 year) | 27.5% |
| Worst drawdown (1 year) | -21.2% |
| Average daily value traded | 10.67M EUR |
| Dividend yield | 3.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Koninklijke Philips is a Dutch technology company based in Amsterdam that focuses on health technology. It makes medical imaging systems such as scanners, patient monitoring and diagnostic equipment for hospitals and clinics, and it also offers personal health products including electric toothbrushes, shavers and home health devices. Philips serves healthcare providers, consumers and customers in many countries around the world, combining medical devices with consumer health and personal care offerings.
On this site Koninklijke Philips NV appears as a stock on the London Exchange (UK), code 0LNG, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Koninklijke Philips NV (0LNG) trades on the London Exchange in UK. It last closed at EUR 23.38 on 21 October 2026.
Its price-based Market X-Ray is 58 out of 100 (a fair price profile), ranking 1,509 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 1.1% and over the last three months it rose 2.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 48 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | 0.7% | ||
| From 52-week high | -11.9% | ||
| Momentum | 47 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 2.0% | ||
| 6-month return | 0.5% | ||
| 12-month return, skipping the last month | -7.6% | ||
| Stability (higher is calmer) | 69 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 27.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -21.2% | ||
| Liquidity | 74 · Strong | Trades actively. | |
| Average daily value traded | 10.67M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 60 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.6% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | +4.1% |
|---|---|
| 1 month | +7.0% |
| 3 months | +2.0% |
| 6 months | +0.5% |
| 1 year | −1.1% |
| 3 years | +52.4% |
| 5 years | −24.2% |
Signals
| 50-day / 200-day average | 22.35 / 23.22 |
|---|---|
| Golden / death cross (60 days) | Death, 29 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.67 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 12 May 2026 | EUR 0.8500 |
| 12 May 2025 | EUR 0.8500 |
| 9 May 2024 | EUR 0.2168 |
| 11 May 2023 | EUR 0.9183 |
| 12 May 2022 | EUR 0.8500 |
| 10 May 2021 | EUR 0.8500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.